AAAAAA
Results: 1-25/41
Authors:
Munshi, A
Pappas, G
Honda, T
McDonnell, TJ
Younes, A
Li, Y
Meyn, RE
Citation: A. Munshi et al., TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2, ONCOGENE, 20(29), 2001, pp. 3757-3765
Authors:
Takahashi, S
Yotnda, P
Roosseau, RF
Mei, ZY
Smith, S
Rill, D
Younes, A
Brenner, MK
Citation: S. Takahashi et al., Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma, CANC GENE T, 8(5), 2001, pp. 378-387
Authors:
Younes, A
Preti, HA
Hagemeister, FB
McLaughlin, P
Romaguera, JE
Rodriguez, MA
Samuels, BI
Palmer, JL
Cabanillas, F
Citation: A. Younes et al., Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma, ANN ONCOL, 12(7), 2001, pp. 923-927
Authors:
Younes, A
Citation: A. Younes, Cd40 ligand therapy of lymphoma patients, J CL ONCOL, 19(23), 2001, pp. 4351-4352
Authors:
Rodriguez, J
Munsell, M
Yazji, S
Hagemeister, FB
Younes, A
Andersson, B
Giralt, S
Gajewski, J
de Lima, M
Couriel, D
Romaguera, J
Cobanillas, FF
Champlin, RE
Khouri, IF
Citation: J. Rodriguez et al., Impact of high-dose chemotherapy on peripheral T-cell lymphomas, J CL ONCOL, 19(17), 2001, pp. 3766-3770
Authors:
van Besien, K
Rodriguez, A
Tomany, S
Younes, A
Donate, M
Sarris, A
Giralt, S
Mehra, R
Andersson, B
Gajewski, J
Champlin, R
Cabanillas, F
Citation: K. Van Besien et al., Phase II study of a high-dose ifosfamide-based chemotherapy regimen with growth factor rescue in recurrent aggressive NHL. High response rates and limited toxicity, but limited impact on long-term survival, BONE MAR TR, 27(4), 2001, pp. 397-404
Authors:
Hadi, U
Younes, A
Ghosseini, S
Tawil, A
Citation: U. Hadi et al., Median palatine cyst: an unusual presentation of a rare entity, BR J ORAL M, 39(4), 2001, pp. 278-281
Authors:
Witte, D
Chirala, M
Younes, A
Li, Y
Younes, M
Citation: D. Witte et al., Estrogen receptor beta is expressed in human colorectal adenocarcinoma, HUMAN PATH, 32(9), 2001, pp. 940-944
Authors:
Mann, S
Laucirica, R
Carlson, N
Younes, PS
Ali, N
Younes, A
Li, Y
Younes, M
Citation: S. Mann et al., Estrogen receptor beta expression in invasive breast cancer, HUMAN PATH, 32(1), 2001, pp. 113-118
Authors:
Engelder, T
Haith, BF
Younes, A
Citation: T. Engelder et al., Horizontal slip along Alleghanian joints of the Appalachian plateau: evidence showing that mild penetrative strain does little to change the pristineappearance of early joints, TECTONOPHYS, 336(1-4), 2001, pp. 31-41
Authors:
Fiumara, P
Younes, A
Citation: P. Fiumara et A. Younes, CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (APO-2L) in haematological malignancies, BR J HAEM, 113(2), 2001, pp. 265-274
Authors:
Fiumara, P
Snell, V
Li, Y
Mukhopadhyay, A
Younes, M
Gillenwater, AM
Cabanillas, F
Aggarwal, BB
Younes, A
Citation: P. Fiumara et al., Functional expression of receptor activator of nuclear factor kappa B in Hodgkin disease cell lines, BLOOD, 98(9), 2001, pp. 2784-2790
Authors:
Fiumara, P
Cabanillas, F
Younes, A
Citation: P. Fiumara et al., Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers, BLOOD, 98(9), 2001, pp. 2877-2878
Authors:
Khouri, IF
Saliba, RM
Giralt, SA
Lee, MS
Okoroji, GJ
Hagemeister, FB
Korbling, M
Younes, A
Ippoliti, C
Gajewski, JL
McLaughlin, P
Anderlini, P
Donato, ML
Cabanillas, FF
Champlin, RE
Citation: If. Khouri et al., Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality, BLOOD, 98(13), 2001, pp. 3595-3599
Authors:
Hamdan, AL
Sharara, AI
Younes, A
Fuleihan, N
Citation: Al. Hamdan et al., Effect of aggressive therapy on laryngeal symptoms and voice characteristics in patients with gastroesophageal reflux, ACT OTO-LAR, 121(7), 2001, pp. 868-872
Authors:
Younes, A
Cristofanilli, M
McLaughlin, P
Hagemeister, FB
Weber, D
Mesina, O
Cabanillas, F
Citation: A. Younes et al., Experience with 9-cis retinoic acid in patients with relapsed and refractory non-Hodgkin's lymphoma, LEUK LYMPH, 40(1-2), 2000, pp. 79-85
Authors:
Sarris, AH
Psyrri, A
Hagemeister, F
Romaguera, J
McLaughlin, P
Rodriguez, MA
Bachier, C
Younes, A
Mesina, O
Oholendt, M
Medeiros, LJ
Samuels, B
Adams, LM
Cabanillas, F
Citation: Ah. Sarris et al., Infusional vinorelbine in relapsed or refractory lymphomas, LEUK LYMPH, 39(3-4), 2000, pp. 291-299
Authors:
Romaguera, JE
Khouri, IF
Kantarjian, HM
Hagemeister, FB
Rodriguez, MA
McLaughlin, P
Sarris, AH
Younes, A
Rodriguez, J
Cabanillas, F
Citation: Je. Romaguera et al., Untreated aggressive mantle cell lymphoma: Results with intensive chemotherapy without stem cell transplant in elderly patients, LEUK LYMPH, 39(1-2), 2000, pp. 77-85
Authors:
Lopez-Guillermo, A
Cabanillas, F
McLaughlin, P
Smith, T
Hagemeister, F
Rodriguez, MA
Romaguera, JE
Younes, A
Sarris, AH
Preti, HA
Pugh, W
Lee, MS
Citation: A. Lopez-guillermo et al., Molecular response assessed by PCR is the most important factor predictingfailure-free survival in indolent follicular lymphoma: Update of the MDACCseries, ANN ONCOL, 11, 2000, pp. 137-140
Authors:
Younes, A
Pepe, S
Barron, BA
Spurgeon, HA
Lakatta, EG
Caffrey, JL
Citation: A. Younes et al., Cardiac synthesis, processing, and coronary release of enkephalin-related peptides, AM J P-HEAR, 279(4), 2000, pp. H1989-H1998
Authors:
McLaughlin, P
Hagemeister, FB
Rodriguez, MA
Sarris, AH
Pate, O
Younes, A
Lee, MS
Dang, NH
Romaguera, JE
Preti, AH
McAda, N
Cabanillas, F
Citation: P. Mclaughlin et al., Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma, SEMIN ONCOL, 27(6), 2000, pp. 37-41
Authors:
King, K
Younes, A
Citation: K. King et A. Younes, Ifosfamide- and paclitaxel-based treatment of relapsed and refractory lymphoma, SEMIN ONCOL, 27(1), 2000, pp. 14-22
Authors:
Younes, M
Lechago, J
Ertan, A
Finnie, D
Younes, A
Citation: M. Younes et al., Decreased expression of Fas (CD95/APO1) associated with goblet cell metaplasia in Barrett's esophagus, HUMAN PATH, 31(4), 2000, pp. 434-438
Authors:
Younes, M
Schwartz, MR
Ertan, A
Finnie, D
Younes, A
Citation: M. Younes et al., Eas ligand expression in esophageal carcinomas and their lymph node metastases, CANCER, 88(3), 2000, pp. 524-528
Authors:
Clodi, K
Wimmer, D
Li, Y
Goodwin, R
Jaeger, U
Mann, G
Gadner, H
Younes, A
Citation: K. Clodi et al., Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells, BR J HAEM, 111(2), 2000, pp. 580-586